Cargando…

Combined inhibition of JAK(1,2)/Stat3-PD-L1 signaling pathway suppresses the immune escape of castration-resistant prostate cancer to NK cells in hypoxia

Castration-resistant prostate cancer (CRPC) is difficult to treat in current clinical practice. Hypoxia is an important feature of the CRPC microenvironment and is closely associated with the progress of CRPC invasion. However, no research has been performed on the immune escape of CRPC from NK cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Li-Jun, Ma, Qi, Zhu, Jin, Li, Jian, Xue, Bo-Xin, Gao, Jie, Sun, Chuan-Yang, Zang, Ya-Chen, Zhou, Yi-Bin, Yang, Dong-Rong, Shan, Yu-Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983983/ https://www.ncbi.nlm.nih.gov/pubmed/29693186 http://dx.doi.org/10.3892/mmr.2018.8905

Ejemplares similares

Inhibition of IL‐6‐JAK/Stat3 signaling in castration‐resistant prostate cancer cells enhances the NK cell‐mediated cytotoxicity via alteration of PD‐L1/NKG2D ligand levels
por: Xu, LiJun, et al.
Publicado: (2018)

Enzalutamide-Resistant Progression of Castration-Resistant Prostate Cancer Is Driven via the JAK2/STAT1-Dependent Pathway
por: Luo, Yong, et al.
Publicado: (2021)

ATM-JAK-PD-L1 signaling pathway inhibition decreases EMT and metastasis of androgen-independent prostate cancer
por: Zhang, Lan, et al.
Publicado: (2018)

AIM2 fosters lung adenocarcinoma immune escape by modulating PD-L1 expression in tumor-associated macrophages via JAK/STAT3
por: Ye, Hua, et al.
Publicado: (2023)

CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK/STAT signaling pathway
por: Li, Cheng, et al.
Publicado: (2021)

JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
por: Gotthardt, Dagmar, et al.
Publicado: (2019)

Transcriptional, Epigenetic and Pharmacological Control of JAK/STAT Pathway in NK Cells
por: Scarno, Gianluca, et al.
Publicado: (2019)

JAK-STAT1 Signaling Pathway Is an Early Response to Helicobacter pylori Infection and Contributes to Immune Escape and Gastric Carcinogenesis
por: Li, Xue, et al.
Publicado: (2022)

Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
por: Bellucci, Roberto, et al.
Publicado: (2015)

IFNγ-induced PD-L1 expression is JAK2 but not JAK1 dependent and its inhibition enhances NK-cetuximab mediated ADCC of HNSCC cells
por: Concha-Benavente, Fernando, et al.
Publicado: (2014)

EGCG Inhibits Tumor Growth in Melanoma by Targeting JAK-STAT Signaling and Its Downstream PD-L1/PD-L2-PD1 Axis in Tumors and Enhancing Cytotoxic T-Cell Responses
por: Ravindran Menon, Dinoop, et al.
Publicado: (2021)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T-cell lymphoma, nasal type
por: Liu, Jumei, et al.
Publicado: (2019)

Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide
por: Chen, Jinghong, et al.
Publicado: (2023)

Anti-PD1 up-regulates PD-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an IFN-γ-associated JAK-STAT pathway
por: Xue, Weili, et al.
Publicado: (2019)

Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade
por: Lv, Jiancheng, et al.
Publicado: (2023)

Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
por: Liu, Yang, et al.
Publicado: (2022)

Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling
por: Zhu, Ping, et al.
Publicado: (2022)

MTHFD2 promotes PD‐L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer
por: Li, Linzhi, et al.
Publicado: (2023)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
por: Jiang, Xianjie, et al.
Publicado: (2019)

Astragaloside IV protects cardiomyocytes against hypoxia injury via HIF-1α and the JAK2/STAT3 pathway
por: Li, Bei, et al.
Publicado: (2021)

PD‐L1 expression is mainly regulated by interferon gamma associated with JAK‐STAT pathway in gastric cancer
por: Mimura, Kousaku, et al.
Publicado: (2017)

Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
por: Yang, Shuqun, et al.
Publicado: (2015)

Hypoxia Impairs NK Cell Cytotoxicity through SHP-1-Mediated Attenuation of STAT3 and ERK Signaling Pathways
por: Teng, Rui, et al.
Publicado: (2020)

Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
por: Lee, Seungbok, et al.
Publicado: (2015)

Computational models of the JAK1/2-STAT1 signaling
por: Gambin, Anna, et al.
Publicado: (2013)

Tofacitinib Ameliorates Lipopolysaccharide-Induced Acute Kidney Injury by Blocking the JAK-STAT1/STAT3 Signaling Pathway
por: Yun, Yang, et al.
Publicado: (2021)

JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
por: Govaerts, Inge, et al.
Publicado: (2019)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

NK cell modulation by JAK inhibition
por: Schönberg, Kathrin, et al.
Publicado: (2015)

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
por: Boyle, D L, et al.
Publicado: (2015)

The molecular basis of JAK/STAT inhibition by SOCS1
por: Liau, Nicholas P. D., et al.
Publicado: (2018)

The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer
por: Lo, U‐Ging, et al.
Publicado: (2022)

JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis
por: Vian, Laura, et al.
Publicado: (2019)

Infectious Bronchitis Virus Nsp14 Degrades JAK1 to Inhibit the JAK-STAT Signaling Pathway in HD11 Cells
por: Ma, Peng, et al.
Publicado: (2022)

PD-L1 expression increased by IFN-γ via JAK2-STAT1 signaling and predicts a poor survival in colorectal cancer
por: Zhao, Tiancheng, et al.
Publicado: (2020)

Corrigendum to “Hypoxia Impairs NK Cell Cytotoxicity through SHP-1-Mediated Attenuation of STAT3 and ERK Signaling Pathways”
por: Teng, Rui, et al.
Publicado: (2021)

The Interaction of the IFNγ/JAK/STAT1 and JAK/STAT3 Signalling Pathways in EGFR-Mutated Lung Adenocarcinoma Cells
por: Han, Yaguang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9v5cat2i2aia21rknog66b2b0e